Tag: BAC
No posts to display
Top News
SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia
Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.
- Our Sponsors Ad -